Liabilities of Kairos Pharma, LTD. from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Kairos Pharma, LTD. quarterly Liabilities in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
Kairos Pharma, LTD. Liabilities for the quarter ending 31 Dec 2024 was $992,000, a 67% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Change (%)

Kairos Pharma, LTD. Quarterly Liabilities (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$992,000	-$2,051,000	-67%	31 Dec 2024	10-K	15 Apr 2025	2024	FY
Q3 2024	$1,672,000			30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q4 2023	$3,043,000			31 Dec 2023	10-K	15 Apr 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.